Systematic Brain Natriuretic Peptide Measurement for Cardiac Screening in Patients with Severe Obesity: The OLECOEUR Study
Obesity Facts · 2024
DOI: 10.1159/000538766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Facts, 2024. Verfasst von Claire Carette und 9 weiteren Autor:innen. Beteiligte Einrichtung: Service de Nutrition, Centre Spécialisé Obésité, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Obesity, Morbid, Heart Failure, Echocardiography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Heart failure (HF) is difficult to diagnose in obese patients because of cardiovascular and pulmonary comorbidities associated with physical deconditioning, all of which lead to dyspnea.
Methods
The OLECOEUR study is a prospective screening for HF using systematic brain natriuretic peptide (BNP) measurement in ambulatory patients with obesity from a department of Nutrition (Paris, France). Clinical, biological, and echocardiographic data were extracted from electronic medical records.
Results
We included 1,506 patients middle-aged (mean age: 47.2 ± 14.6 years old) with severe obesity (mean body mass index: 40.4 ± 6.6 kg/m2). Patients with BNP ≥35 pg/mL had left heart remodeling including thicker interventricular septum (10.4 ± 2.0 vs. 9.6 ± 1.8 mm; p = 0.0008), higher left ventricular mass (89.9 ± 24.3 vs. 77.2 ± 20.0 g/m2; p = 0.0009), and significant changes in both left and right atria consistent with a higher proportion of prior atrial fibrillation. Markers of right heart remodeling on echocardiography were also significantly higher (pulmonary artery systolic pressure: 33.3 ± 17.3 vs. 24.5 ± 6.3 mm Hg; p = 0.0002).
Conclusion
The OLECOEUR study shows left and right subclinical cardiac remodeling in obese patients screened for HF with systematic dosing of BNP with usual cut-off of 35 pg/mL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Nutrition, Centre Spécialisé Obésité, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France.
- CIC1418 and DMU CARTE, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France.
- Université Paris Cité, Paris, France.
- Informatique Médicale, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France.
- INSERM, PARCC, Paris, France.
- INSERM, CRESS, UMR1153, Paris, France.
Zitieren
APA
Carette, C., Okamba-Belle, D., Hirlemann, M., Wack, M., Domenge, O., Jannot, A. S., Czernichow, S., Rives-Lange, C., Fayol, A., & Hulot, J. S. (2024). Systematic Brain Natriuretic Peptide Measurement for Cardiac Screening in Patients with Severe Obesity: The OLECOEUR Study. Obesity Facts. https://doi.org/10.1159/000538766
Vancouver
Carette C, Okamba-Belle D, Hirlemann M, Wack M, Domenge O, Jannot AS, et al. Systematic Brain Natriuretic Peptide Measurement for Cardiac Screening in Patients with Severe Obesity: The OLECOEUR Study. Obesity Facts. 2024. doi:10.1159/000538766
BibTeX
@article{Carette2024,
author = {Carette, Claire and Okamba-Belle, Diana and Hirlemann, Mélanie and Wack, Maxime and Domenge, Orianne and Jannot, Anne-Sophie and Czernichow, Sébastien and Rives-Lange, Claire and Fayol, Antoine and Hulot, Jean-Sébastien},
title = {Systematic Brain Natriuretic Peptide Measurement for Cardiac Screening in Patients with Severe Obesity: The OLECOEUR Study},
journal = {Obesity Facts},
year = {2024},
doi = {10.1159/000538766}
}
EUVIMED